Detection of furosemide, sibutramine, and/or fluoxetine adulteration in “all natural” weight loss consumer products at an international mail facility satellite laboratory using handheld/portable rapid screening instruments
Year: 2026
Type: article
Abstract: A total of 97 consumer products claiming to be "all natural" or providing label graphics indicating potential weight-loss effects, were examined by a US Food and Drug Administration (FDA) National Forensic Chemistry Center (NFCC) International Mail Facility (IMF) satellite laboratory. All products were examined using a toolkit consisting of a handheld Raman spectrometer, portable Fourier-transform infrared (FT-IR) spectrometer, portable ambient ionization direct analysis in real-time mass spectrometer (DART-MS), and/or portable gas chromatography-mass spectrometry (GC-MS) instrument. Conclusive results were achieved for 89 out of 97 products using the satellite laboratory toolkit only. The remaining eight products were sent to the NFCC full-service laboratory for additional analysis using liquid chromatography with mass spectrometry (LC-MS). All 97 products were found to be adulterated with active pharmaceutical ingredients (APIs), with each containing at least two of the following drugs: furosemide, sibutramine, and/or fluoxetine. Furosemide and fluoxetine are only available with a prescription and sibutramine is a Schedule IV controlled substance. Furthermore, sibutramine, fluoxetine, and furosemide are all under the scope of section 801(u) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and therefore have been identified by FDA as a significant public health risk. Overall, the results of this study helped prevent over 24,000 adulterated consumer product capsules from reaching unsuspecting American consumers during a two-year timeframe.
Source: Journal of Forensic Sciences
Authors: Michael D. Thatcher, Hannah E. Hill, Marie Marseille, Allison M. Reimer, Anvi Patel, Caroline M. Kelley, Brian L. Boyd, Christina Fernandez, Cierra D. Bell, Daurice J. McClain, Jerae D. Byrd, Jingjing Pan, Joan Cantellops Figueroa, Joseph Carver, Lisa M. Lorenz, Megan. E. Sterling, Melissa E. Collins, Muhammad Altaf, Sara E. Kern, Teneka L. Jean‐Louis, Adam Lanzarotta
Institution: United States Food and Drug Administration
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7235612522
